Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6

Glycogen synthase kinase-3 (GSK-3) is a key regulator of many cellular signaling pathways. Unlike most kinases, GSK-3 is controlled by inhibition rather than by specific activation. In the insulin and several other signaling pathways, phosphorylation of a serine present in a conserved sequence near...

Full description

Bibliographic Details
Main Authors: Jennifer L Stamos, Matthew Ling-Hon Chu, Michael D Enos, Niket Shah, William I Weis
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2014-03-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/01998
_version_ 1811200302168145920
author Jennifer L Stamos
Matthew Ling-Hon Chu
Michael D Enos
Niket Shah
William I Weis
author_facet Jennifer L Stamos
Matthew Ling-Hon Chu
Michael D Enos
Niket Shah
William I Weis
author_sort Jennifer L Stamos
collection DOAJ
description Glycogen synthase kinase-3 (GSK-3) is a key regulator of many cellular signaling pathways. Unlike most kinases, GSK-3 is controlled by inhibition rather than by specific activation. In the insulin and several other signaling pathways, phosphorylation of a serine present in a conserved sequence near the amino terminus of GSK-3 generates an auto-inhibitory peptide. In contrast, Wnt/β-catenin signal transduction requires phosphorylation of Ser/Pro rich sequences present in the Wnt co-receptors LRP5/6, and these motifs inhibit GSK-3 activity. We present crystal structures of GSK-3 bound to its phosphorylated N-terminus and to two of the phosphorylated LRP6 motifs. A conserved loop unique to GSK-3 undergoes a dramatic conformational change that clamps the bound pseudo-substrate peptides, and reveals the mechanism of primed substrate recognition. The structures rationalize target sequence preferences and suggest avenues for the design of inhibitors selective for a subset of pathways regulated by GSK-3.
first_indexed 2024-04-12T02:02:29Z
format Article
id doaj.art-7c15a261e8bd48adb929dd7023bf8741
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T02:02:29Z
publishDate 2014-03-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-7c15a261e8bd48adb929dd7023bf87412022-12-22T03:52:38ZengeLife Sciences Publications LtdeLife2050-084X2014-03-01310.7554/eLife.01998Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6Jennifer L Stamos0Matthew Ling-Hon Chu1Michael D Enos2Niket Shah3William I Weis4Department of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesDepartment of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesDepartment of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesDepartment of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesDepartment of Structural Biology, Stanford University, Stanford, United States; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United StatesGlycogen synthase kinase-3 (GSK-3) is a key regulator of many cellular signaling pathways. Unlike most kinases, GSK-3 is controlled by inhibition rather than by specific activation. In the insulin and several other signaling pathways, phosphorylation of a serine present in a conserved sequence near the amino terminus of GSK-3 generates an auto-inhibitory peptide. In contrast, Wnt/β-catenin signal transduction requires phosphorylation of Ser/Pro rich sequences present in the Wnt co-receptors LRP5/6, and these motifs inhibit GSK-3 activity. We present crystal structures of GSK-3 bound to its phosphorylated N-terminus and to two of the phosphorylated LRP6 motifs. A conserved loop unique to GSK-3 undergoes a dramatic conformational change that clamps the bound pseudo-substrate peptides, and reveals the mechanism of primed substrate recognition. The structures rationalize target sequence preferences and suggest avenues for the design of inhibitors selective for a subset of pathways regulated by GSK-3.https://elifesciences.org/articles/01998GSK-3Wnt signalingprotein kinaseLRP6
spellingShingle Jennifer L Stamos
Matthew Ling-Hon Chu
Michael D Enos
Niket Shah
William I Weis
Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
eLife
GSK-3
Wnt signaling
protein kinase
LRP6
title Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
title_full Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
title_fullStr Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
title_full_unstemmed Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
title_short Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
title_sort structural basis of gsk 3 inhibition by n terminal phosphorylation and by the wnt receptor lrp6
topic GSK-3
Wnt signaling
protein kinase
LRP6
url https://elifesciences.org/articles/01998
work_keys_str_mv AT jenniferlstamos structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6
AT matthewlinghonchu structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6
AT michaeldenos structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6
AT niketshah structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6
AT williamiweis structuralbasisofgsk3inhibitionbynterminalphosphorylationandbythewntreceptorlrp6